問卷
Log In
繁中 EN
TPIDB
TPIDB Outstanding PI
TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberMK-3543-006
Active

2023-11-01 - 2031-12-31

Phase III

Recruiting5

ICD-10C88.8

Other malignant immunoproliferative diseases

ICD-10C94.40

Acute panmyelosis with myelofibrosis not having achieved remission

ICD-10C94.41

Acute panmyelosis with myelofibrosis, in remission

ICD-10C94.42

Acute panmyelosis with myelofibrosis, in relapse

ICD-10C94.6

Myelodysplastic disease, not classified

ICD-10D46.9

Myelodysplastic syndrome, unspecified

ICD-10D46.A

Refractory cytopenia with multilineage dysplasia

ICD-10D46.B

Refractory cytopenia with multilineage dysplasia and ring sideroblasts

ICD-10D46.C

Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality

ICD-10D46.Z

Other myelodysplastic syndromes

ICD-10D47.1

Chronic myeloproliferative disease

ICD-10D47.3

Essential (hemorrhagic) thrombocythemia

ICD-10D47.9

Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified

ICD-10D47.Z1

Post-transplant lymphoproliferative disorder (PTLD)

ICD-10D47.Z9

Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue

ICD-9238.7

Neoplasm of uncertain behavior of other lymphatic and hematopoietic tissues

  • Trial Applicant

    Merck Sharp & Dohme (I.A.) LLC

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator HSUAN JEN SHIH Division of Hematology & Oncology
Linkou Chang Gung Medical Foundation

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 廖碧涵 Division of Hematology & Oncology
Kaoshiung Chang Gung Memorial Hospital of the C.G.M.F.

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator
Chiayi Chang Gung Memorial Hospital of the C.G.M.F.

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Tsai-Yun Chen 無
National Taiwan University Hospital

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator HSIN-AN HOU Division of Hematology & Oncology
National Taiwan University Hospital

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    15 participants

  • Global

    340 participants

聯絡我們

台灣臨床試驗主持人資料庫 TPIDB

All Contents Copyright 2020 台灣臨床試驗主持人資料庫TPIDB